Aclarion (ACON) Stock Analysis

What Aclarion does

Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.

Key metrics

ETFs linked to ACON

Broad-market and Healthcare sector ETFs an investor holding Aclarion is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ACON fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Aclarion?

Aclarion trades under the ticker ACON on NASDAQ.

Which exchange is ACON listed on?

ACON is listed on NASDAQ.

What sector does Aclarion operate in?

Aclarion is classified in the Healthcare sector (Medical - Healthcare Information Services industry).

How can PortView help analyze ACON in a portfolio?

PortView shows ACON's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.